Tengion is a leader in the field of regenerative medicine, developing new human tissues and organs derived from a patient’s own cells. Tengion’s patented technology has the potential to allow adults and children with organ failure to have functioning organs built from their own tissues. At the Dow Jones Venture Wire Health Care Innovations conference, PodTech’s Jennifer Jones talks with CEO Steven Nichtberger about how his company is planning to save lives through these scientific advances.
Tags: Tengion, Dow Jones, Steven Nichtberger
Press:
pr@podtech.net
Sales:
sales@podtech.net
Feedback:
feedback@podtech.net
PodTech Network is committed to protecting your online privacy while providing you with the most useful and enjoyable Web experience possible.
Copyright ©2008 PodTech.net. All rights reserved. Modified: Sun, 20 May 2012 19:22:22 -0700